Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure FR-2021-30/2140 – Updated – measures in France
|Country||France , applies nationwide|
|Time period||Open ended, started on 19 July 2021|
|Type||Legislations or other statutory regulations|
Protection of workers, adaptation of workplace
– Occupational health and safety
|Author||Frédéric Turlan (IRshare) and Eurofound|
|Measure added||10 January 2022 (updated 25 April 2022)|
The scope of application of the regulations on the prevention of biological risks is set out in Article R. 4421-1 of the Labour Code. These regulations apply to companies whose activities expose workers to biological risks. In the context of the COVID-19 pandemic, many companies that do not normally fall within the scope of this regulation were subject to it because of the possibility of workers being exposed to the agent causing the epidemic in their professional context.
Classification 2 in group 3 of biological pathogens
Furthermore, the order of 18 December 2020 on the classification of the SARS-CoV-2 coronavirus in the list of biological pathogens, which came into force on 19 July 2021, classified SARS-CoV-2 in group 3 of biological pathogens. This leads to additional requirements under the biohazard prevention regulations for the protection of exposed workers.
Adaptation of the regulation
However, while the application of certain provisions does not raise any difficulties, others appear to be unsuited to these particular circumstances of an epidemic, such as those relating to reinforced medical monitoring or the implementation of a certain number of prevention measures specific to establishments whose activity usually exposes workers to biological risk (signposting of premises, containment measures, eyewash devices, for example). Decree no. 2021-951 of 16 July 2021 is therefore intended to adapt certain provisions relating to the prevention of biological risks to businesses that do not usually fall under this regulation, in order to best prevent the exposure of workers to SARS-CoV-2 but also to adapt the rules so that they are proportionate and applicable in establishments normally excluded from the scope of this regulation.
Employees in standard employment
Workers in non-standard forms of employment
|Applies to all businesses||Does not apply to citizens|
Company / Companies
No special funding required
Social partners' role in designing the measure and form of involvement:
|Trade unions||Employers' organisations|
|Form||Not applicable||Not applicable|
Social partners' role in the implementation, monitoring and assessment phase:
No specific information about social partners involvement.
No specific information about social partners views.
Eurofound (2022), Regulations on biological risks of employees exposed to COVID-19, measure FR-2021-30/2140 (measures in France), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/FR-2021-30_2140.html
19 May 2022
This publication consists of individual country reports on working life during 2021 for 28 countries (the 27 EU Member States and Norway).Publication
24 June 2020
COVID-19: Policy responses across Europe
This report aims to present an overview of both large-scale government measures and collective agreements that impact on large groups of workers.
16 June 2022
Throughout 2021, the second year of the COVID-19 pandemic, specific occupational health and safety rules were reintroduced due to increases in infection rates.Article
16 June 2022
Back to work after COVID-19: Testing, vaccines and green certificates
In the second pandemic year 2021, access to one's place of work was increasingly dependent on providing proof of either having been tested, vaccinated or recovered from COVID-19 in several countries.
Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.